Demo Data from VLDB 2026 / reviewers in the wild / expert
Anil Sorathiya
dblp:49/3403 · also Anilkumar Sorathiya
· DBLP profile ↗
2ranked-venue papers
1as first author
0since 2021 · last 2011
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Systems, architecture and hardware · 1Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% | |
| Theoretical computer science
1 paper |
Mathematical optimization · 100% |
Topics — the 4 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › synthetic biology
metabolic engineering |
0.1 | 1 | 2011 | Design of robust metabolic pathways · DAC 2011 |
Bioinformatics and computational biology › synthetic biology
metabolic pathway design |
0.1 | 1 | 2011 | Design of robust metabolic pathways · DAC 2011 |
Mathematical optimization
multi-objective optimization |
0.0 | 1 | 2011 | Design of robust metabolic pathways · DAC 2011 |
Mathematical optimization › multi-objective optimization
pareto optimization |
0.0 | 1 | 2011 | Design of robust metabolic pathways · DAC 2011 |
Methods — techniques the papers use, named apart from their topics
multi-objective optimization · 0.2PMO2 · 0.2
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2011 | Design of robust metabolic pathwaysabstractIn this paper we investigate plant photosynthesis and microbial fuel cells. We report the following: 1) we introduce and validate a novel multi-objective optimization algorithm, PMO2; 2) in photosynthesis we increase the yield of 135%, while in Geobacter sulfurreducens we determine the tradeoff for growth versus redox properties; 3) finally, we discuss Pareto-Front as an estimator of robust metabolic pathways. Renato Umeton, Giovanni Stracquadanio, Anil Sorathiya, Pietro Liò, Alessio Papini, Giuseppe Nicosia |
DAC | 3 |
| 2010 | Formal reasoning on qualitative models of coinfection of HIV and Tuberculosis and HAART therapyabstractBACKGROUND: Several diseases, many of which nowadays pandemic, consist of multifactorial pathologies. Paradigmatic examples come from the immune response to pathogens, in which cases the effects of different infections combine together, yielding complex mutual feedback, often a positive one that boosts infection progression in a scenario that can easily become lethal. HIV is one such infection, which weakens the immune system favouring the insurgence of opportunistic infections, amongst which Tuberculosis (TB). The treatment with antiretroviral therapies has shown effective in reducing mortality. An in-depth understanding of complex systems, like the one consisting of HIV, TB and related therapies, is an open great challenge, on the boundaries of bioinformatics, computational and systems biology. RESULTS: We present a simplified formalisation of the highly dynamic system consisting of HIV, TB and related therapies, at the cellular level. The progression of the disease (AIDS) depends hence on interactions between viruses, cells, chemokines, the high mutation rate of viruses, the immune response of individuals and the interaction between drugs and infection dynamics. We first discuss a deterministic model of dual infection (HIV and TB) which is able to capture the long-term dynamics of CD4 T cells, viruses and Tumour Necrosis Factor (TNF). We contrast this model with a stochastic approach which captures intrinsic fluctuations of the biological processes. Furthermore, we also integrate automated reasoning techniques, i.e. probabilistic model checking, in our formal analysis. Beyond numerical simulations, model checking allows general properties (effectiveness of anti-HIV therapies) to be verified against the models by means of an automated procedure. Our work stresses the growing importance and flexibility of model checking techniques in bioinformatics. In this paper we i) describe HIV as a complex case of infectious diseases; ii) provide a number of different formal descriptions that suitably account for aspects of interests; iii) suggest that the integration of different models together with automated reasoning techniques can improve the understanding of infections and therapies through formal analysis methodologies. CONCLUSION: We argue that the described methodology suitably supports the study of viral infections in a formal, automated and expressive manner. We envisage a long-term contribution of this kind of approaches to clinical Bioinformatics and Translational Medicine. Anil Sorathiya, Andrea Bracciali, Pietro Liò |
BMC Bioinform. | 1 |